Sarepta Therapeutics to Present at the BofA Securities 2022 Healthcare Conference

Rhea-AI Summary

Sarepta Therapeutics (NASDAQ:SRPT) will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 11, 2022, at 9:20 a.m. P.T. The event will take place at the Encore Hotel in Las Vegas, Nevada, and will be webcast live on the company's investor relations website. This discussion will cover Sarepta's commitment to developing precision genetic medicine for rare diseases, as well as their extensive pipeline, which includes over 40 programs targeting Duchenne muscular dystrophy and limb-girdle muscular dystrophies. The webcast will remain archived for 90 days.

CAMBRIDGE, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 9:20 a.m. P.T. / 12:20 p.m. E.T. The fireside chat will be held at the Encore Hotel in Las Vegas, Nev.

The presentation will be webcast live under the Events & Presentations section of the investor relations section of Sarepta’s website at https://investorrelations.sarepta.com/events-presentations and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com

Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com

FAQ

When is Sarepta Therapeutics participating in the BofA Securities 2022 Healthcare Conference?

Sarepta Therapeutics will participate in the BofA Securities 2022 Healthcare Conference on May 11, 2022.

What time will the fireside chat start for Sarepta at the conference?

The fireside chat will start at 9:20 a.m. P.T. / 12:20 p.m. E.T.

Where is the BofA Securities 2022 Healthcare Conference being held?

The conference will be held at the Encore Hotel in Las Vegas, Nevada.

How can I watch the Sarepta Therapeutics fireside chat?

The fireside chat will be webcast live on Sarepta's investor relations website.

How long will the Sarepta webcast be available after the presentation?

The webcast will be archived for 90 days following the presentation.

What is Sarepta Therapeutics focused on in their research?

Sarepta Therapeutics is focused on precision genetic medicine for rare diseases, particularly Duchenne muscular dystrophy and limb-girdle muscular dystrophies.